Correction: Microglial 5-LOX-activating protein antagonism alleviates leukotriene-driven neuroinflammation - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Inhibition of Microglial 5-LOX-Activating Protein Mitigates Neuroinflammation Induced by Leukotrienes

  • By

  • Julia Konings

  • Fleur Mingneau

  • Serhii Chornyi

  • Cathrin E. Hansen

  • Rianne T. M. van der Burgt

  • Tessa G. van Elk

  • Laura Bolkaerts

  • Bo Batens

  • Gábor Tóth

  • Ingela Lanekoff

  • Frédéric M. Vaz

  • Alessio Cardilli

  • Marie Sels

  • Susanne M. A. van der Pol

  • Helga E. de Vries

  • Martin Giera

  • Oliver Werz

  • Sofie Kessels

  • Sanne G. S. Verberk

  • Jeroen F. J. Bogie

  • Merel Rijnsburger

  • Jerome J. A. Hendriks

  • Gijs Kooij

  • September 4, 2026

Share

  • 1

    The article discusses a correction in Acta Neuropathologica, volume 152, article 16.

  • 2

    The DOI for the correction is 10.1007/s00401-026-03055-w.

  • 3

    The author's name was incorrectly presented as 'Rianne T. M. van der Brugt'.

  • 4

    The correct name is 'Rianne T. M. van der Burgt'.

  • 5

    The original article has been corrected to reflect the accurate author name.

Original Source(s)

Correction: Microglial 5-LOX-activating protein antagonism alleviates leukotriene-driven neuroinflammation

  • by Julia Konings, Fleur Mingneau, Serhii Chornyi, Cathrin E. Hansen, Rianne T. M. van der Burgt, Tessa G. van Elk, Laura Bolkaerts, Bo Batens, Gábor Tóth, Ingela Lanekoff, Frédéric M. Vaz, Alessio Cardilli, Marie Sels, Susanne M. A. van der Pol, Helga E. de Vries, Martin Giera, Oliver Werz, Sofie Kessels, Sanne G. S. Verberk, Jeroen F. J. Bogie, Merel Rijnsburger, Jerome J. A. Hendriks, Gijs Kooij

  • September 4, 2026

Related Content

FDA approves first therapy for Alexander disease

The antisense oligonucleotide reduces production of the abnormal protein that accumulates in supportive cells in the brain.

Error in Author Name

  • September 3, 2026

Estriol may ease menopause-related cognitive decline

Women reported improvement across 6 cognitive domains during 12 months of estriol-based treatment, while murine models suggested a potential astrocyte-mediated mechanism.